FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

35852211000001103: Losartan 50mg / Hydrochlorothiazide 12.5mg tablets (Medreich Plc) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Oct 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
110092301000001115 Losartan 50mg / Hydrochlorothiazide 12.5mg tablets (Medreich Plc) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
110092401000001111 Losartan 50mg / Hydrochlorothiazide 12.5mg tablets (Medreich Plc) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Losartan 50mg / Hydrochlorothiazide 12.5mg tablets (Medreich Plc) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Losartan 50mg / Hydrochlorothiazide 12.5mg tablets (Medreich Plc) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Losartan 50mg / Hydrochlorothiazide 12.5mg tablets (Medreich Plc) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Losartan 50mg / Hydrochlorothiazide 12.5mg tablets (Medreich Plc) Is a Product containing precisely hydrochlorothiazide 12.5 milligram and losartan potassium 50 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Losartan 50mg / Hydrochlorothiazide 12.5mg tablets (Medreich Plc) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Losartan 50mg / Hydrochlorothiazide 12.5mg tablets (Medreich Plc) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Losartan 50mg / Hydrochlorothiazide 12.5mg tablets (Medreich Plc) Has basis of strength substance Losartan potassium true Inferred relationship Existential restriction modifier 2
Losartan 50mg / Hydrochlorothiazide 12.5mg tablets (Medreich Plc) Has basis of strength substance Hydrochlorothiazide true Inferred relationship Existential restriction modifier 1
Losartan 50mg / Hydrochlorothiazide 12.5mg tablets (Medreich Plc) Has presentation strength numerator value 12.5 false Inferred relationship Existential restriction modifier 1
Losartan 50mg / Hydrochlorothiazide 12.5mg tablets (Medreich Plc) Has presentation strength numerator value 50 false Inferred relationship Existential restriction modifier 2
Losartan 50mg / Hydrochlorothiazide 12.5mg tablets (Medreich Plc) Has presentation strength numerator unit milligram true Inferred relationship Existential restriction modifier 1
Losartan 50mg / Hydrochlorothiazide 12.5mg tablets (Medreich Plc) Has presentation strength numerator unit milligram true Inferred relationship Existential restriction modifier 2
Losartan 50mg / Hydrochlorothiazide 12.5mg tablets (Medreich Plc) Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 1
Losartan 50mg / Hydrochlorothiazide 12.5mg tablets (Medreich Plc) Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 2
Losartan 50mg / Hydrochlorothiazide 12.5mg tablets (Medreich Plc) Has presentation strength denominator unit Tablet true Inferred relationship Existential restriction modifier 1
Losartan 50mg / Hydrochlorothiazide 12.5mg tablets (Medreich Plc) Has presentation strength denominator unit Tablet true Inferred relationship Existential restriction modifier 2
Losartan 50mg / Hydrochlorothiazide 12.5mg tablets (Medreich Plc) Has precise active ingredient Losartan potassium true Inferred relationship Existential restriction modifier 2
Losartan 50mg / Hydrochlorothiazide 12.5mg tablets (Medreich Plc) Has precise active ingredient Hydrochlorothiazide true Inferred relationship Existential restriction modifier 1
Losartan 50mg / Hydrochlorothiazide 12.5mg tablets (Medreich Plc) Has unit of presentation Tablet true Inferred relationship Existential restriction modifier
Losartan 50mg / Hydrochlorothiazide 12.5mg tablets (Medreich Plc) Count of base of active ingredient 2 false Inferred relationship Existential restriction modifier
Losartan 50mg / Hydrochlorothiazide 12.5mg tablets (Medreich Plc) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Losartan 50mg / Hydrochlorothiazide 12.5mg tablets (Medreich Plc) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Losartan 50mg / Hydrochlorothiazide 12.5mg tablets (Medreich Plc) Has specific active ingredient Losartan potassium true Inferred relationship Existential restriction modifier
Losartan 50mg / Hydrochlorothiazide 12.5mg tablets (Medreich Plc) Has specific active ingredient Hydrochlorothiazide true Inferred relationship Existential restriction modifier
Losartan 50mg / Hydrochlorothiazide 12.5mg tablets (Medreich Plc) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Losartan 50mg / Hydrochlorothiazide 12.5mg tablets (Medreich Plc) Has excipient Lactose false Inferred relationship Existential restriction modifier
Losartan 50mg / Hydrochlorothiazide 12.5mg tablets (Medreich Plc) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Losartan 50mg / Hydrochlorothiazide 12.5mg tablets (Medreich Plc) 28 tablet 2 x 14 tablets Has AMP True Losartan 50mg / Hydrochlorothiazide 12.5mg tablets (Medreich Plc) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start